Aperbio Technologies is proud to announce the grand opening of its Asia-Pacific (APAC) regional office in Singapore — a landmark milestone in the company’s global expansion and commitment to innovation, regional collaboration, and advancing precision technologies for life sciences.

This strategic expansion strengthens Aperbio Technologies’ footprint across the APAC region, enabling the company to better serve partners, accelerate scientific innovation, and drive regional initiatives aligned with its mission: 

The opening celebration brought together esteemed collaborators and guests who have played an instrumental role in Aperbio’s growth story. The company extends its deepest gratitude to Stilla Technologies, EDB Singapore, Singapore FOZL Group, NovageneAIT Genomics, Chemopharm Group of Companies, PT Sentrum, Darwin Science, and Impaco for their valued presence and continued support.

“The launch of our Singapore office represents more than just a physical expansion—it reflects our ongoing investment in scientific excellence, strong partnerships, and a shared vision for the future of precision life sciences,” said Spokesperson at Aperbio Technologies. “We are excited to collaborate even more closely with our regional partners and bring our global expertise to local markets.”

As the company looks to the future, the new APAC hub will play a critical role in fostering innovation, localizing solutions, and accelerating cross-border scientific progress in collaboration with leading stakeholders in the region.